Skip to main content
. Author manuscript; available in PMC: 2025 Mar 1.
Published in final edited form as: J Card Fail. 2023 Sep 25;30(3):452–459. doi: 10.1016/j.cardfail.2023.08.024

Table 2.

Targeted high-risk medications, depending on subtype of heart failure

Heart Failure (any subtype) Heart Failure With Reduced Ejection Fraction
Oral nonsteroidal antiinflammatory drugs Cilostazol
Dipeptidyl peptidase-4 inhibitors High-risk antiarrhythmics
 Alogliptin  Disopyramide
 Saxagliptin  Dronedarone
Thiazolidinediones  Flecainide
 Pioglitazone  Propafenone
 Rosiglitazone Select calcium channel blockers
 Diltiazem
 Verapamil
 Nifedipine